(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

IMMUNOCAP

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

IMMUNOCAP

ST13

US500000076096212

Class

1, 5

Filing

76096212

Registration

2555198

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

22

Latest update

10/28/2022

Trademark type

Word

Nice classes

1, 5

Filing date

07/25/2000

Registration date

04/02/2002

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

09/28/2022

Last transaction

10/28/2022

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

First use anywhere

1991-00-00

First use in commerce

1991-00-00

Drawing code

1

Owner type

16

Owner location

UPPSALA, SE

Examiner

JENKINS JR, CHARLES L

Law office

L50

Current location

GENERIC WEB UPDATE

Holders and representatives

Holders

PHADIA AB
P. A. (pessoa física)
Pharmacia & Upjohn Diagnostics AB

Representatives

Kenya Williams Thermo Fisher Scientific

Technical classification

Nice Classes

Class 1Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Chemical reagents and diagnostic preparations for in vitro use as an aid in clinical diagnosis in scientific laboratoriesin the medical and diagnostic industry

Class 5

Chemical reagents and diagnostic preparations for in vitro use in medical and veterinary laboratories; chemical reagents for medical and veterinary purposesdiagnostic preparations for medical purposes

Publications

History of USPTO decisions and trademark events.

22 publications found

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

09/28/2022

RNL2

REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)

09/28/2022

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

09/28/2022

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

09/28/2022

E89R

TEAS SECTION 8 & 9 RECEIVED

04/04/2022

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

04/02/2021

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

02/26/2014

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

03/08/2012

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

03/08/2012

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

03/08/2012

E89R

TEAS SECTION 8 & 9 RECEIVED

03/06/2012

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

06/21/2008

E815

TEAS SECTION 8 & 15 RECEIVED

06/06/2008

CFIT

CASE FILE IN TICRS

05/17/2007

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

08/23/2006

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

08/09/2006

R.PR

REGISTERED-PRINCIPAL REGISTER

04/02/2002

PUBO

PUBLISHED FOR OPPOSITION

01/08/2002

NPUB

NOTICE OF PUBLICATION

12/19/2001

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

09/24/2001

CNRT

NON-FINAL ACTION MAILED

12/15/2000

DOCK

ASSIGNED TO EXAMINER

12/14/2000

Continuous trademark protection

Get notified about every new filing that threatens IMMUNOCAP or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.